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This studywas designed to elucidate the acute toxicity ofArtocarpus altilis leaf and bark extracts. In acute toxicity study, nomortality
or any toxic reaction was recorded in any group after 14 days of administering the extracts (2000mgKg−1 BW).The extracts (ALA,
ABA, ALM, and ABM) did not cause any behavioural or physical changes in experimental rats.There was no significant (𝑃 ≤ 0.05)
difference in the biochemical parameters analysed between the groups. Slight elevation in activities of AST and ALT in extract
treated groups was observed, but this did not exert any deleterious effect on the normal metabolism which was supported by the
histopathology of liver. Histopathological studies showed no remarkable changes after 14 days of oral administration of ALA, ABA,
ALM, and ABM extracts. The study contributes to establishing the nontoxic quality parameters of Artocarpus altilis leaf and bark
parts and the results suggest the safety of the extracts in therapeutic uses.
1. Introduction
India has an ancient heritage of traditionalmedicine. Accord-
ing to a survey by WHO, it is estimated that about 80%
of people living in developing countries rely on traditional
plant-based medicine for their basic health care needs [1, 2].
Natural products have numerous therapeutic approaches,
contributed to understanding biochemical pathways, and
are valuable tools in biological chemistry and molecular
and cellular biology [3]. Plants used in traditional medicine
contain wide range of ingredients that can be used to treat
chronic as well as infectious diseases [4]. The potential
medicinal value of plants lies in the bioactive compounds that
produce a definite physiological action on the human body
[5]. Bioactive compounds derived from medicinal plants can
be useful but might have serious dose-related side effects.
However, till now the dose-related toxicity of medicinal
plants, particularly at the histological side, is notmuch known
or explored [6]. Toxicity studies are conducted to assess
the degree of toxicity of a component for humans, animals,
or the environment, to investigate the mechanism of toxic
chemicals, or to develop new or improved tests for specific
types of chemically induced effects. The rationale for doing
acute toxic study is to investigate the adverse effects that may
occur on first exposure to a single dose of a substance and
ensure its safe utilization.They also determine the maximum
nonlethal dose and provide preliminary information relevant
to single exposure or overdosage in humans. For pharmaceu-
ticals, the results are used in combination with the efficacy
of bioactives to decide whether the beneficial effects of the
treatment would outweigh the risks of adverse side effects, if
any, and to establish a safe dose for use in clinical trials [7].
Thesemedicinal plants/metabolites then can be safely utilized
as nutraceutical or can be incorporated into food formulation
as functional ingredient.
Artocarpus altilis (Parkinson) Fosberg (Moraceae) is a
tree of moderate size and is widely cultivated in tropics
as staple crop, animal feed, and construction material. Its
leaves have been used traditionally for the treatment of
liver cirrhosis, hypertension, and diabetes [8, 9]. Pharma-
cological studies report the presence of flavonoids, [10, 11]
triterpenoids [12], and prenylflavonoids [8] in A. altilis and
some flavonoids have shown anti-inflammatory activities [13]
and also inhibit 5-lipoxygenase of cultured mastocytoma
cells [14]. The traditional usage of leaf to treat hypertension
[15] and diabetes [16, 17] has been proven scientifically.
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Only few studies have been conducted to demonstrate the
pharmacological or biological effects of A. altilis; however,
there are no toxicological effects reported, and hence the
present study is the first to be documented on the toxicity
aspects. A. altilis is being explored for various biological
activities such as antihyperglycemic activity [16, 17] in our
laboratory and hence the present work was undertaken to
study acute toxicological effect of various extracts of A. altilis
leaf and bark parts.
2. Materials and Methods
2.1. Chemicals and Reagents. Alanine aminotransferase
(ALT), aspartate aminotransferase (AST), alkaline phospha-
tase (ALP), total protein, albumin, urea, creatinine, total
bilirubin, triglycerides, and total cholesterol assay kits were
purchased from Aggappe Diagnostics, Ernakulam, India.
Reduced glutathione (GSH) and 5,5-dithio(bis) nitrobenzoic
acid (DTNB) were purchased from Sigma-Aldrich, Banga-
lore, India. All the chemicals and reagents used in the study
were of analytical grade.
2.2. Collection and Preparation of Samples. The leaf and bark
parts ofArtocarpus altiliswere collected fromMysore district
of Karnataka, India, and subsequently identified by Dr. G. R.
Shivamurthy, Department of Studies in Botany, University of
Mysore, Mysore, India.The samples were thoroughly washed
under running water to remove adhering dirt and other
foreign particles from the surface, dried overnight (50∘C),
powdered, passed through 60 mesh sieve (BS), and stored in
airtight container at 4∘C till further use.
Various extracts of A. altilis leaf and bark used for in vivo
biological experiments were studied for acute toxicological
effect on animals according toOECD guidelines 420 [18].The
cold aqueous extracts of A. altilis leaf and bark were prepared
by extracting powdered material with cold water (RT) in a
mechanical shaker (24 h), filtered, and freeze dried in freeze
drier (Thermo Modulyo D, Hong Kong). 80% of methanol
extract was prepared by taking 15 g sample, extracted with
50mL of 80% of methanol (methanol : water—8 : 2 ratio) in
a mechanical shaker (6 hrs). The extracts were evaporated
at 40∘C under reduced pressure to dryness in a rotary
evaporator (Superfit, India) and stored in air tight container
at 4∘C until further use. Sample codes are as follows: cold
aqueous extracts; leaf—ALA, bark—ABA, 80% methanol
extracts leaf—ALM, bark—ABM.
2.3. Experimental Animals. Adult Wistar strain albino rats
weighing around 140–180 g were acclimatized for 14 days
under standard conditions. The rats were housed in the
polyacrylic cages, maintained at 25 ± 2∘C, 45% to 60%
RH, and 12 h photoperiod. During acclimatization period,
the animals were observed for general conditions every
day. Standard pellet diet (Amrut feeds, Pune, India) and
water ad libitum were provided. The experimental pro-
tocol of toxicological studies was reviewed and approved
by the Institutional Animal Ethical Committee (IAEC) for
the purpose of control and supervision of experiments on
animals (UOM/IAEC/29/2011).
2.4. Acute Toxicity Studies. The animals were grouped into
5 groups: group I—control; group II—ALA; group III—
ALM; group IV—ABA; group V—ABM consisting of 6
animals each (3 males, 3 females) using randomized block
design. According to OECD 420 guidelines, the animals were
administered with 2000mg kg−1 BW of extracts.The extracts
were given in the form of suspensions, orally by gavage
for 14 days. The animals were observed individually after
the initiation of dose during first 30min and at every half
an hour interval for 6 hours and thereafter once in 24 hr
for 14 days. Individual records were maintained to record
physical or behavioural changes such as skin and fur, eyes and
mucous membrane, respiratory, circulatory, autonomic and
central nervous systems (ANS and CNS, resp.), somatomotor
activity, behaviour pattern, and mortality. Observations were
also made for presence of tremors, convulsions, salivation,
diarrhoea, lethargy, sleep, and coma. At the end of the study
period, animals were euthanized and decapitated.
2.5. Biochemical Estimations. Blood was collected and serum
was separated after centrifuge at 2500×g for 20min. Activ-
ities of alanine amino transferase (ALT), aspartate amino-
transferase (AST), and alkaline phosphatase (ALP) were
determined in serum along with estimation of total protein,
albumin, urea, creatinine, total bilirubin, total cholesterol,
and triglycerides (TGL) using respective standard kits. Glu-
tathione (GSH) and thiobarbituric reactive oxygen species
(TBARS) as markers of lipid peroxidation were determined
by the methods of Ellman [19] and Ohkawa et al. [20],
respectively, in serum, liver, and kidney homogenates.
2.6. Histopathological Procedures. Various organs like liver,
kidney, heart, brain, and spleen were excised immediately,
washed with phosphate buffered saline, and weighed. Small
portions of liver were fixed in 10% formaldehyde, then
dehydrated in graduate ethanol (50–100%), cleared in xylene,
and embedded in paraffin.The sections (4-5𝜇m)were stained
with haematoxylin and eosin (H-E) dye and examined with
photomicroscope (400x) for any histopathological changes.
2.7. Statistical Analysis. The values are expressed as mean ±
SD. The data was subjected to one-way ANOVA followed by
Tukey’s multiple comparisons test for significant difference
(𝑃 ≤ 0.05) using SPSS 16.0 software.
3. Results and Discussion
The yield of the different extracts was calculated and
expressed as percentage (w/w). The leaf 80% MeOH extract
gave maximum yield of 21.67% (w/w) followed by leaf aque-
ous extract (7.87%), bark 80% MeOH, and aqueous extracts
(7.07% and 1.45%), respectively.
3.1. Acute Toxicity Studies. In the present acute toxicity study
of different A. altilis leaf and bark extracts, the animals were
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treated with limit test dose of 2000mg−1 kg BW (OECD
guidelines 420, 2001). The data on toxic symptoms and
behavioural and other changes are presented as record sheet
in Table 1. All the extracts did not show any toxic symptom
during the study period. There were no significant changes
in behaviour, ANS, or CNS and no mortality was observed
in any of the animals. There was no significant (𝑃 ≥ 0.05)
changes between weights of major organs in relation to their
body weights (Table 2).
3.2. Biochemical Estimations. The activities of hepatic
enzymes and selected biochemical parameters are repre-
sented in Figure 1 and Table 3, respectively. ALA and ABM
showed significant (𝑃 ≤ 0.05) higher ALT activity. Although
statistically there was significance (𝑃 ≤ 0.05) between the
activities of ALP, ALT, and AST in experimental groups, it
did not affect the normal metabolism or behavioural pattern.
The data on serum total protein, albumin, creatinine, total
bilirubin, and urea shown in Tables 3 and 4 contain the total
protein and albumin contents in organs, namely, liver, kidney,
and brain. There was no significant (𝑃 ≤ 0.05) difference
observed in biochemical parameters between the groups
except in the total protein and albumin contents of brain.
The triglyceride and total cholesterol contents in serum,
liver, kidney, and brain of control and extract treated groups
are shown in Figures 2 and 3, respectively. It was interesting
to note that the total cholesterol levels were significantly
(𝑃 ≤ 0.05) low in all the extract treated groups compared
to control group. The TBARS (Figure 4) and glutathione
(Figure 5) levels in serum along with liver, kidney, and brain
homogenates were analysed in all the groups. The treatment
with leaf and bark extracts did not show any adverse effects
on cellular defence mechanisms against oxidative stress. The
results suggested that leaf extracts performed better than the
bark extracts.
3.3. Histopathological Procedures. The histological sections
of the control and extract treated groups are represented
in Figure 6. There were no detectable changes in cellular
morphology of hepatocytes. The hepatic architecture was
normal with well-defined central vein. No necrosis, steatosis,
chronic inflammatory infiltration, or degenerative changes
were observed in any of the extract treated animals. The
biochemical and histopathology results of leaf and bark
extracts are comparable, and the reason for these similarities
may be that the samples are from the same plant. The
preliminary investigation on the presence of phytochemicals
in the extracts of A. altilis leaf and bark parts revealed
that maximum phytochemical constituents were present in
methanol extracts of both AL and AB. Terpenoids and
triterpenoids were present in all solvent extracts of AL and
AB. Saponins and tannins were present in aqueous extracts,
while steroids were present in petroleum ether, benzene, and
methanol extracts of AL and AB [21].
Medicinal/herbal plants and their preparations are being
used from thousands of years in all types of traditionalmedic-
inal practices; one of the reasons is due to their nontoxic
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Figure 1: Serum hepatic enzymes levels of different groups (U L−1).
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Table 2: Relative body (BW) and organ weights of control and experimental groups (g) (values in parenthesis indicate organ-BW ratio)
(𝑛 = 6).
Group Initial BW Final BW Liver Kidney Heart Brain Spleen
Con 161a ± 9.67 152a ± 7.63 4.29
a
± 0.53
(2.28)
1.05a ± 0.27
(0.69)
0.45a ± 0.15
(0.29)
1.42a ± 0.95
(0.93)
0.32a ± 0.01
(0.21)
ALA 183a ± 5.83 168a ± 2.01 5.19
a
± 0.31
(3.08)
1.29a ± 1.38
(0.76)
0.62a ± 0.23
(0.36)
1.56a ± 0.80
(0.92)
0.35a ± 0.01
(0.20)
ALM 161a ± 4.31 150a ± 8.43 4.46
a
± 0.75
(2.97)
1.16a ± 0.25
(0.77)
0.60a ± 0.42
(0.40)
1.57a ± 0.77
(1.04)
0.34a ± 0.01
(0.22)
ABA 172a ± 6.66 155a ± 5.28 4.11
a
± 0.77
(2.65)
1.16a ± 0.37
(0.78)
0.61a ± 0.64
(0.39)
1.50a ± 0.97
(0.96)
0.28a ± 0.03
(0.18)
ABM 172a ± 5.52 184b ± 5.96 5.52
a
± 0.87
(3.00)
1.42a ± 0.31
(0.77)
0.62a ± 0.28
(0.33)
1.47a ± 1.02
(0.79)
0.36a ± 0.02
(0.19)
ALA: leaf aqueous extract, ALM: leaf 80% MeOH, ABA: bark aqueous extract, ABM: bark 80% MeOH extract.
Mean values carrying different superscripts a, b, c . . . in columns differ significantly (𝑃 ≤ 0.05).
Table 3: Changes in biochemical parameters in serum of control and experimental groups.
Group T. pro(g dL−1)
Albumin
(g dL−1)
Creatinine
(mg dL−1)
T. bilirubin
(mg dL−1)
Urea
(mg dL−1)
Con 4.38a ± 1.28 3.94b ± 0.28 1.20b ± 0.02 0.43b ± 0.02 74a ± 0.63
ALA 4.04a ± 1.15 3.01b ± 0.42 0.74b ± 0.02 0.30b ± 0.01 58a ± 0.37
ABA 4.86a ± 0.59 3.27b ± 0.35 0.44a ± 0.01 0.12a ± 0.03 51a ± 0.91
ALM 3.97a ± 0.66 2.96ab ± 0.75 0.60b ± 0.15 0.41b ± 0.01 63a ± 0.84
ABM 4.17a ± 0.98 2.03a ± 0.32 0.60b ± 0.18 0.61c ± 0.03 72a ± 0.65
ALA: leaf aqueous extract, ALM: leaf 80% MeOH, ABA: bark aqueous extract, ABM: bark 80% MeOH extract.
Mean values carrying different superscripts a, b, c . . . in columns differ significantly (𝑃 ≤ 0.05).
Table 4: Total protein and albumin contents in liver, kidney, and brain (g dL−1).
Groups TP Albumin
Liver Kidney Brain Liver Kidney Brain
Con 1.51b ± 0.82 0.44a ± 0.12 0.73 ± 0.08 0.45 ± 0.02 0.45 ± 0.02 0.63 ± 0.03
ALA 1.49b ± 0.76 0.76a ± 0.29 1.15 ± 0.15 0.24 ± 0.05 0.64 ± 0.15 0.77 ± 0.08
ABA 0.71a ± 0.25 0.53a ± 0.10 0.98 ± 0.17 0.55 ± 0.07 0.5 ± 0.02 0.87 ± 0.06
ALM 1.15ab ± 0.40 0.47a ± 0.37 0.51 ± 0.08 0.66 ± 0.02 0.37 ± 0.05 0.31 ± 0.02
ABM 1.44b ± 0.42 0.59a ± 0.12 1.54 ± 0.21 0.83 ± 0.11 0.42 ± 0.05 1.26 ± 0.05
ALA: leaf aqueous extract, ALM: leaf 80% MeOH, ABA: bark aqueous extract, ABM: bark 80% MeOH extract.
Mean values carrying different superscripts a, b, c . . . in columns differ significantly (𝑃 ≤ 0.05).
effect. They are rich sources of numerous bioactive compo-
nents which can prevent, treat, and help in the management
of several disease/disorders and till date only few plants have
been explored for their potential pharmacological activities.
Although the biological effects and bioactive components
are identified, there is no scientific documentation of their
toxicological effects.
Synthetic drugs usually consist of a single chemical, while
medicinal plants have complexmixture of 400 ormore chem-
icals. The side effects of a single compound or bioactive can
be evaluated but in the crude plant extract it is very difficult
to understand the complex interactions and synergies taking
place between hundreds of plant metabolites [22]. These
medicinal herbs contain numerous complex compounds,
oftenmucilages, tannins, polysaccharides, and so forth which
maymodulate or modify the effects of bioactive components.
Studies have also shown that the biological effects exerted by
extracts of whole plants cannot be mimicked by administer-
ing isolated purified constituents of the plant [23]. Hence, it is
very essential to assert the beneficial as well as the toxic effects
of these plant derivatives before recommending and used as
supplement or nutraceutical for any disease condition.
The description for any toxicity varies for foods and
medicinal plant derivatives. Commonly consumed foods
6 Journal of Toxicology
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contain constituents that could be allergic or considered
as toxic, to list a few, alpha gliadin produced by wheat,
rye, and oats, cyanogenic glycosides present in many fruit
seeds, lectins in pulses mainly in soya and red kidney beans,
alkaloids present in Solanaceae family, thiocyanates of the
Brassica vegetables, and so on. Despite the presence of these
constituents, all the above foods are regarded as safe through-
out the world; the main reason is the amounts or levels of
allergic/toxic components present. Most components if taken
in excess might reverse the affirmative effect. Similarly, water
and oxygen which are essential for life can kill in excessive
amounts, so the quantity is often an important consideration
[24, 25].
The results confirm the safety of aqueous and 80%
MeOH extracts of A. altilis leaf and bark parts, as it did
not exert any allergic symptoms in experimental animals
and also by observing physical and behavioural changes
after administration of the sample, which is one of the
simple ways to assert the toxic effects. The liver is the vital
organ, involved in the maintenance of metabolic function
and detoxification of drugs. If the normal metabolic function
is hampered due to hepatic damage, there will be elevation
in serum levels of hepatic health markers like ALT, AST,
ALP, and bilirubin [26]. The hepatic enzyme activities and
the biochemical parameters analysed proved the nontoxicity
of the sample extracts. Although the activities of AST, ALP,
and total bilirubin content differed significantly (𝑃 ≤ 0.05)
in the groups, they did not exert any remarkable changes on
the normal metabolic processes. Marginal elevation in the
activities of AST and ALP extract treated groups may not
be an indication of hepatic damage, which can be confirmed
by other biochemical parameters and histopathology of
liver.
4. Conclusion
A. altilis is used in traditional medical systems, time-tested,
and used to treat various ailments till date. These traditions
have successfully set an example of natural resource use
Journal of Toxicology 7
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Figure 6: Histopathological changes in liver of control and extract treated groups. (a) Control; (b) ALA; (c) ABA; (d) ALM; (e) ABM.
in curing many complex diseases. From the results of this
acute toxic study, it is inferred that A. altilis leaf and bark
extracts are safe to be utilized as functional ingredient or as
nutraceutical.
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